| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Hebert K, Santoro L, Monnier M, Castan F, Berkane I, Assénat E, Fersing C, Gélibert P, Pouget JP, Bardiès M, Kotzki PO, Deshayes E. Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38637144 DOI: 10.2967/jnumed.123.267023 |
0.01 |
|
| 2023 |
Garcia-Prada CD, Carmes L, Atis S, Parach A, Bertolet A, Jarlier M, Poty S, Garcia DS, Shin WG, Du Manoir S, Schuemann J, Tillement O, Lux F, Constanzo J, Pouget JP. Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37857502 DOI: 10.2967/jnumed.123.265418 |
0.01 |
|
| 2023 |
Pouget JP, Chan TA, Galluzzi L, Constanzo J. Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors. Trends in Cancer. PMID 37612188 DOI: 10.1016/j.trecan.2023.07.014 |
0.01 |
|
| 2022 |
Constanzo J, Garcia-Prada CD, Pouget JP. Clonogenic assay to measure bystander cytotoxicity of targeted alpha-particle therapy. Methods in Cell Biology. 174: 137-149. PMID 36710047 DOI: 10.1016/bs.mcb.2022.08.005 |
0.01 |
|
| 2022 |
Pouget JP, Konijnenberg M, Eberlein U, Glatting G, Gabina PM, Herrmann K, Holm S, Strigari L, van Leeuwen FWB, Lassmann M. An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36066665 DOI: 10.1007/s00259-022-05934-2 |
0.01 |
|
| 2022 |
Nonnekens J, Pouget JP, Cornelissen B, Terry SYA. Status of radiobiology in molecular radionuclide therapy - Hope for the future. Nuclear Medicine and Biology. 45-46. PMID 35561638 DOI: 10.1016/j.nucmedbio.2022.04.008 |
0.01 |
|
| 2022 |
Fidani T, Desmarets G, Goupil J, Pouget JP, Boudousq V. A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence: A New Pitfall? Clinical Nuclear Medicine. PMID 35353745 DOI: 10.1097/RLU.0000000000004133 |
0.01 |
|
| 2022 |
Constanzo J, Galluzzi L, Pouget JP. Immunostimulatory effects of radioimmunotherapy. Journal For Immunotherapy of Cancer. 10. PMID 35190377 DOI: 10.1136/jitc-2021-004403 |
0.01 |
|
| 2021 |
Pavlopoulou A, Asfa S, Gioukakis E, Mavragani IV, Nikitaki Z, Takan I, Pouget JP, Harrison L, Georgakilas AG. Investigation of the Biological Implications of Complex DNA Damage with Emphasis in Cancer Radiotherapy through a Systems Biology Approach. Molecules (Basel, Switzerland). 26. PMID 34946681 DOI: 10.3390/molecules26247602 |
0.01 |
|
| 2021 |
Pouget JP, Santoro L, Piron B, Paillas S, Ladjohounlou R, Pichard A, Poty S, Deshayes E, Constanzo J, Bardiès M. From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience. Nuclear Medicine and Biology. 53-64. PMID 34922279 DOI: 10.1016/j.nucmedbio.2021.11.005 |
0.01 |
|
| 2021 |
Al Ojaimi Y, Blin T, Lamamy J, Gracia M, Pitiot A, Denevault-Sabourin C, Joubert N, Pouget JP, Gouilleux-Gruart V, Heuzé-Vourc'h N, Lanznaster D, Poty S, Sécher T. Therapeutic antibodies - natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics. 108022. PMID 34687769 DOI: 10.1016/j.pharmthera.2021.108022 |
0.01 |
|
| 2021 |
Pouget JP, Constanzo J. Revisiting the Radiobiology of Targeted Alpha Therapy. Frontiers in Medicine. 8: 692436. PMID 34386508 DOI: 10.3389/fmed.2021.692436 |
0.01 |
|
| 2021 |
Karam J, Constanzo J, Pichard A, Gros L, Chopineau J, Morille M, Pouget JP. Rapid communication: insights into the role of extracellular vesicles during Auger radioimmunotherapy. International Journal of Radiation Biology. 1-10. PMID 34270378 DOI: 10.1080/09553002.2021.1955999 |
0.01 |
|
| 2021 |
Cornelissen B, Terry S, Nonnekens J, Pouget JP. First Symposium of the European Working Group on the Radiobiology of Molecular Radiotherapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 62: 14N-15N. PMID 34244371 |
0.01 |
|
| 2021 |
Idrissou MB, Pichard A, Tee B, Kibedi T, Poty S, Pouget JP. Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide. Pharmaceutics. 13. PMID 34209637 DOI: 10.3390/pharmaceutics13070980 |
0.01 |
|
| 2021 |
Constanzo J, Faget J, Ursino C, Badie C, Pouget JP. Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway. Frontiers in Immunology. 12: 680503. PMID 34079557 DOI: 10.3389/fimmu.2021.680503 |
0.01 |
|
| 2021 |
Pouget J, Constanzo J. Revisiting the Radiobiology of Targeted Alpha Therapy Frontiers in Medicine. 8. DOI: 10.3389/fmed.2021.692436 |
0.01 |
|
| 2020 |
Rečnik LM, Cantelli C, Fersing C, Gongora C, Pouget JP, Lisowski V. Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systems. Bioorganic & Medicinal Chemistry Letters. 30: 127527. PMID 32890684 DOI: 10.1016/j.bmcl.2020.127527 |
0.01 |
|
| 2020 |
Mora-Ramirez E, Santoro L, Cassol E, Ocampo-Ramos JC, Clayton N, Kayal G, Chouaf S, Trauchessec D, Pouget JP, Kotzki PO, Deshayes E, Bardiès M. Comparison of commercial dosimetric software platforms in patients treated with Lu-DOTATATE for peptide receptor radionuclide therapy. Medical Physics. PMID 32632928 DOI: 10.1002/mp.14375 |
0.01 |
|
| 2019 |
Pichard A, Marcatili S, Karam J, Constanzo J, Ladjohounlou R, Courteau A, Jarlier M, Bonnefoy N, Patzke S, Stenberg V, Coopman P, Cartron G, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, ... ... Pouget JP, et al. The therapeutic effectiveness of Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest. Leukemia. PMID 31836849 DOI: 10.1038/s41375-019-0677-4 |
0.01 |
|
| 2019 |
Rondon A, Schmitt S, Briat A, Ty N, Maigne L, Quintana M, Membreno R, Zeglis BM, Navarro-Teulon I, Pouget JP, Chezal JM, Miot-Noirault E, Moreau E, Degoul F. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept. Theranostics. 9: 6706-6718. PMID 31588245 DOI: 10.7150/Thno.35461 |
0.01 |
|
| 2019 |
Terry SYA, Nonnekens J, Aerts A, Baatout S, de Jong M, Cornelissen B, Pouget JP. Call to arms: need for radiobiology in molecular radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31069454 DOI: 10.1007/s00259-019-04334-3 |
0.01 |
|
| 2019 |
Ladjohounlou R, Lozza C, Pichard A, Constanzo J, Karam J, Le Fur P, Deshayes E, Boudousq V, Paillas S, Busson M, Le Blay M, Jarlier M, Marcatili S, Bardiès M, Bruchertseifer F, ... ... Pouget JP, et al. Drugs that modify cholesterol metabolism alter the p38/JNK-mediated targeted and non-targeted response to alpha and Auger radioimmunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31061069 DOI: 10.1158/1078-0432.Ccr-18-3295 |
0.01 |
|
| 2019 |
Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz LB, Roger P, Guiu S, Derocq D, Robin G, Michaud HA, Delpech H, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, ... ... Pouget JP, et al. Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. Journal For Immunotherapy of Cancer. 7: 29. PMID 30717773 DOI: 10.1186/s40425-019-0498-z |
0.01 |
|
| 2018 |
Santoro L, Mora-Ramirez E, Trauchessec D, Chouaf S, Eustache P, Pouget JP, Kotzki PO, Bardiès M, Deshayes E. Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [Lu-[DOTA0, Tyr3]-octreotate. Ejnmmi Research. 8: 103. PMID 30498938 DOI: 10.1186/S13550-018-0459-4 |
0.01 |
|
| 2018 |
Deshayes E, de Forges H, Fraisse J, Eberlé MC, Guillemard S, Fallières A, Pouget JP, Tétreau R, Kotzki PO, Santoro L, Senesse P, Flori N. Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study. Clinical Nutrition (Edinburgh, Scotland). PMID 30209026 DOI: 10.1016/J.Clnu.2018.08.033 |
0.01 |
|
| 2018 |
Deshayes E, Ladjohounlou R, Le Fur P, Pichard A, Lozza C, Boudousq V, Sevestre S, Jarlier M, Kashani R, Koch J, Sosabowski J, Foster J, Chouin N, Bruchertseifer F, Morgenstern A, ... ... Pouget JP, et al. Anti-MISRII radiolabeled antibodies: new tools for a theranostic approach in ovarian cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29674421 DOI: 10.2967/Jnumed.118.208611 |
0.01 |
|
| 2018 |
Pouget JP, Georgakilas AG, Ravanat JL. TARGETED AND OFF-TARGET (BYSTANDER AND ABSCOPAL) EFFECTS OF RADIATION THERAPY: REDOX MECHANISMS AND RISK-BENEFIT ANALYSIS. Antioxidants & Redox Signaling. PMID 29350049 DOI: 10.1089/ars.2017.7267 |
0.01 |
|
| 2018 |
Mora-Ramirez E, Cassol E, Santoro L, Chouaf S, Trauchessec D, Pouget J, Kotzki P, Deshayes E, Bardiès M. 60 Comparison of organ-based absorbed doses estimations by using PLANET®Dose and OLINDA/EXM V2.0 in patients with peptide receptor radionuclide therapy (PRRT) treated with Lutathera® Physica Medica. 56: 34. DOI: 10.1016/J.EJMP.2018.09.073 |
0.01 |
|
| 2017 |
Rondon A, Ty N, Bequignat JB, Quintana M, Briat A, Witkowski T, Bouchon B, Boucheix C, Miot-Noirault E, Pouget JP, Chezal JM, Navarro-Teulon I, Moreau E, Degoul F. Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models. Scientific Reports. 7: 14918. PMID 29097747 DOI: 10.1038/s41598-017-15051-y |
0.01 |
|
| 2017 |
Estupina P, Fontayne A, Barret JM, Kersual N, Dubreuil O, Le Blay M, Pichard A, Jarlier M, Pugnière M, Chauvin M, Chardès T, Pouget JP, Deshayes E, Rossignol A, Abache T, et al. The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells. Oncotarget. PMID 28427157 DOI: 10.18632/oncotarget.15715 |
0.01 |
|
| 2017 |
Maisonial-Besset A, Witkowski T, Navarro-Teulon I, Berthier-Vergnes O, Fois G, Zhu Y, Besse S, Bawa O, Briat A, Quintana M, Pichard A, Bonnet M, Rubinstein E, Pouget JP, Opolon P, et al. Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer. Oncotarget. 8: 22034-22047. PMID 28423546 DOI: 10.18632/oncotarget.15787 |
0.01 |
|
| 2016 |
Marcatili S, Pichard A, Courteau A, Ladjohounlou R, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, Dahle J, Pouget JP, Bardiès M. Realistic multi-cellular dosimetry for Lu-labelled antibodies: model and application. Physics in Medicine and Biology. 61: 6935-6952. PMID 27617585 DOI: 10.1088/0031-9155/61/19/6935 |
0.01 |
|
| 2016 |
Renard D, Collombier L, Castelli C, Pouget JP, Kotzki PO, Boudousq V. In myotonic dystrophy type 1 reduced FDG-uptake on FDG-PET is most severe in Brodmann area 8. Bmc Neurology. 16: 100. PMID 27411408 DOI: 10.1186/S12883-016-0630-3 |
0.01 |
|
| 2016 |
Paillas S, Ladjohounlou R, Lozza C, Pichard A, Deshayes E, Jarlier M, Sevestre S, Le Blay M, Boudousq V, Sosabowski J, Chardes T, Teulon I, Mairs R, Pouget JP. Localized irradiation of cell membrane by Auger electrons is cytotoxic through oxidative stress-mediated non-targeted effects. Antioxidants & Redox Signaling. PMID 27224059 DOI: 10.1089/Ars.2015.6309 |
0.01 |
|
| 2016 |
Radchenko V, Engle JW, Roy C, Griswold J, Nortier MF, Birnbaum ER, Brugh M, Mirzadeh S, John KD, Fassbender ME, Zhai C, Franssen GM, Petrik M, Laverman P, Decristoforo C, ... ... Pouget J, et al. 18th European Symposium on Radiopharmacy and Radiopharmaceuticals Ejnmmi Radiopharmacy and Chemistry. 1: 10. DOI: 10.1186/S41181-016-0012-6 |
0.01 |
|
| 2016 |
Ladjohounlou R, Pichard A, Boudousq V, Paillas S, Blay ML, Lozza C, Marcatili S, Bardiès M, Torgue J, Navarro-Teulon I, Pouget J-. Contribution of direct and bystander effects to therapeutic efficacy of alpha-RIT using 212Pb-labeled mAbs Radiotherapy and Oncology. 118. DOI: 10.1016/S0167-8140(16)30175-X |
0.01 |
|
| 2016 |
Arnaud F, Paillas S, Pouget J, Incerti S, Bardiès M, Bordage M. Complex cell geometry and sources distribution model for Monte Carlo single cell dosimetry with iodine 125 radioimmunotherapy Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions With Materials and Atoms. 366: 227-233. DOI: 10.1016/J.NIMB.2015.11.008 |
0.01 |
|
| 2015 |
Repetto-Llamazares AH, Larsen RH, Patzke S, Fleten KG, Didierlaurent D, Pichard A, Pouget JP, Dahle J. Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma. Plos One. 10: e0128816. PMID 26066655 DOI: 10.1371/journal.pone.0128816 |
0.01 |
|
| 2015 |
Pouget JP, Lozza C, Deshayes E, Boudousq V, Navarro-Teulon I. Introduction to radiobiology of targeted radionuclide therapy. Frontiers in Medicine. 2: 12. PMID 25853132 DOI: 10.3389/Fmed.2015.00012 |
0.01 |
|
| 2014 |
Kersual N, Garambois V, Chardès T, Pouget JP, Salhi I, Bascoul-Mollevi C, Bibeau F, Busson M, Vié H, Clémenceau B, Behrens CK, Estupina P, Pèlegrin A, Navarro-Teulon I. The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4. Mabs. 6: 1314-26. PMID 25517316 DOI: 10.4161/mabs.29316 |
0.01 |
|
| 2014 |
Perrier M, Busson M, Massasso G, Long J, Boudousq V, Pouget JP, Peyrottes S, Perigaud Ch, Porredon-Guarch C, de Lapuente J, Borras M, Larionova J, Guari Y. ²⁰¹Tl⁺-labelled Prussian blue nanoparticles as contrast agents for SPECT scintigraphy. Nanoscale. 6: 13425-9. PMID 25283238 DOI: 10.1039/C4Nr03044C |
0.01 |
|
| 2014 |
Gardette M, Viallard C, Paillas S, Guerquin-Kern JL, Papon J, Moins N, Labarre P, Desbois N, Wong-Wah-Chung P, Palle S, Wu TD, Pouget JP, Miot-Noirault E, Chezal JM, Degoul F. Evaluation of two (125)I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma. Investigational New Drugs. 32: 587-97. PMID 24691673 DOI: 10.1007/s10637-014-0086-5 |
0.01 |
|
| 2014 |
Piron B, Paillas S, Boudousq V, Pèlegrin A, Bascoul-Mollevi C, Chouin N, Navarro-Teulon I, Pouget JP. DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy. Nuclear Medicine and Biology. 41: e75-83. PMID 24613681 DOI: 10.1016/J.Nucmedbio.2014.01.012 |
0.01 |
|
| 2014 |
Elgqvist J, Frost S, Pouget JP, Albertsson P. The potential and hurdles of targeted alpha therapy - clinical trials and beyond. Frontiers in Oncology. 3: 324. PMID 24459634 DOI: 10.3389/fonc.2013.00324 |
0.01 |
|
| 2014 |
Pouget J-, Pichard A, Boudousq V, Bobyk L, Ladjohounlou R, Paillas S, Blay ML, Busson M, Lozza C, Maquaire P, Torgue J, Navarro-Teulon I. 159: ²¹²Pb-labeled mAbs targeting CEA or HER2 during α-RIT of small peritoneal carcinomatosis – Dose effect relationship? Radiotherapy and Oncology. 110. DOI: 10.1016/S0167-8140(15)34180-3 |
0.01 |
|
| 2014 |
Paillas S, Arnaud F, Chardès T, Mairs R, Navarro-Teulon I, Pèlegrin A, Pouget J. 148: Auger electron emitters labeled to monoclonal antibodies trigger cell membrane-mediated bystander effects Radiotherapy and Oncology. 110: S72. DOI: 10.1016/S0167-8140(15)34169-4 |
0.01 |
|
| 2013 |
Deshayes E, Kraeber-Bodéré F, Vuillez JP, Bardiès M, Teulon I, Pouget JP. Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients. Immunotherapy. 5: 1283-6. PMID 24283837 DOI: 10.2217/imt.13.138 |
0.01 |
|
| 2013 |
Lozza C, Navarro-Teulon I, Pèlegrin A, Pouget JP, Vivès E. Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers. Frontiers in Oncology. 3: 247. PMID 24093086 DOI: 10.3389/fonc.2013.00247 |
0.01 |
|
| 2013 |
Renard D, Vandenberghe R, Collombier L, Kotzki PO, Pouget JP, Boudousq V. Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and individual patient analysis Journal of Neurology. 260: 3055-3064. PMID 24068371 DOI: 10.1007/S00415-013-7117-6 |
0.01 |
|
| 2013 |
Boudousq V, Bobyk L, Busson M, Garambois V, Jarlier M, Charalambatou P, Pèlegrin A, Paillas S, Chouin N, Quenet F, Maquaire P, Torgue J, Navarro-Teulon I, Pouget JP. Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb. Plos One. 8: e69613. PMID 23922757 DOI: 10.1371/Journal.Pone.0069613 |
0.01 |
|
| 2013 |
Navarro-Teulon I, Lozza C, Pèlegrin A, Vivès E, Pouget JP. General overview of radioimmunotherapy of solid tumors. Immunotherapy. 5: 467-87. PMID 23638743 DOI: 10.2217/imt.13.34 |
0.01 |
|
| 2013 |
Mauxion T, Barbet J, Suhard J, Pouget JP, Poirot M, Bardiès M. Improved realism of hybrid mouse models may not be sufficient to generate reference dosimetric data Medical Physics. 40. PMID 23635291 DOI: 10.1118/1.4800801 |
0.01 |
|
| 2013 |
Paillas S, Boudousq V, Piron B, Kersual N, Bardiès M, Chouin N, Bascoul-Mollevi C, Arnaud FX, Pèlegrin A, Navarro-Teulon I, Pouget JP. Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membrane. Nuclear Medicine and Biology. 40: 471-80. PMID 23522976 DOI: 10.1016/J.Nucmedbio.2013.02.001 |
0.01 |
|
| 2012 |
Crouzet J, Boudousq V, Lechiche C, Pouget JP, Kotzki PO, Collombier L, Lavigne JP, Sotto A. Place of 18F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin European Journal of Clinical Microbiology & Infectious Diseases. 31: 1727-1733. PMID 22735898 DOI: 10.1007/S10096-011-1440-6 |
0.01 |
|
| 2012 |
Lacombe J, Solassol J, Ozsahin M, Coelho M, Pouget J, Azria D. OC-32: Quantitative Proteomic Approach to Identify Hypersensitive Patients to Curative Intent Radiotherapy Radiotherapy and Oncology. 104: 31. DOI: 10.1016/S0167-8140(15)34586-2 |
0.01 |
|
| 2011 |
Lacombe J, Solassol J, Pouget JP, Coelho M, Azria D. [Radiosensitivity assays of normal tissues]. Bulletin Du Cancer. 98: 1469-75. PMID 22157594 DOI: 10.1684/bdc.2011.1497 |
0.01 |
|
| 2011 |
Pouget JP, Navarro-Teulon I, Bardiès M, Chouin N, Cartron G, Pèlegrin A, Azria D. Clinical radioimmunotherapy--the role of radiobiology. Nature Reviews. Clinical Oncology. 8: 720-34. PMID 22064461 DOI: 10.1038/nrclinonc.2011.160 |
0.01 |
|
| 2011 |
Nalda E, Mahadea KK, Dematteï C, Kotzki PO, Pouget JP, Boudousq V. Assessment of the Stratos, a new pencil-beam bone densitometer: dosimetry, precision, and cross calibration. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. 14: 395-406. PMID 21839660 DOI: 10.1016/J.Jocd.2011.05.004 |
0.01 |
|
| 2011 |
Ladjemi MZ, Chardes T, Corgnac S, Garambois V, Morisseau S, Robert B, Bascoul-Mollevi C, Ait Arsa I, Jacot W, Pouget JP, Pelegrin A, Navarro-Teulon I. Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice. Breast Cancer Research : Bcr. 13: R17. PMID 21294885 DOI: 10.1186/bcr2826 |
0.01 |
|
| 2010 |
Boudousq V, Ricaud S, Garambois V, Bascoul-Mollevi C, Boutaleb S, Busson M, Quenet F, Colombo PE, Bardiès M, Kotzki PO, Navarro-Teulon I, Pèlegrin A, Pouget JP. Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1748-55. PMID 20956481 DOI: 10.2967/Jnumed.110.080226 |
0.01 |
|
| 2010 |
Busson M, Larbouret C, Teulon I, Kotzki P, Pouget J, Pèlegrin A. R144: Imagerie in vivo des cancers et anticorps monoclonaux Bulletin Du Cancer. 97: S73. DOI: 10.1016/S0007-4551(15)31065-1 |
0.01 |
|
| 2009 |
Santoro L, Boutaleb S, Garambois V, Bascoul-Mollevi C, Boudousq V, Kotzki PO, Pèlegrin M, Navarro-Teulon I, Pèlegrin A, Pouget JP. Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 2033-41. PMID 19910417 DOI: 10.2967/Jnumed.109.066993 |
0.01 |
|
| 2009 |
Boutaleb S, Pouget J, Hindorf C, Pelegrin A, Barbet J, Kotzki P, Bardies M. Impact of Mouse Model on Preclinical Dosimetry in Targeted Radionuclide Therapy Proceedings of the Ieee. 97: 2076-2085. DOI: 10.1109/JPROC.2009.2026921 |
0.01 |
|
| 2008 |
Pouget JP, Santoro L, Raymond L, Chouin N, Bardiès M, Bascoul-Mollevi C, Huguet H, Azria D, Kotzki PO, Pèlegrin M, Vivès E, Pèlegrin A. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiation Research. 170: 192-200. PMID 18666820 DOI: 10.1667/Rr1359.1 |
0.01 |
|
| 2008 |
Piron B, Chouin N, Bardies M, Pelegrin A, Pouget J. p53 Status and Tumor Cell Response to Radioimmunotherapy using 125I-mAbs Radioprotection. 43. DOI: 10.1051/RADIOPRO:2008676 |
0.01 |
|
| 2008 |
Pouget J, Santoro L, Garambois V, Piron B, Boutaleb S, Mollevi C, Chouin N, Bardies M, Vives E, Kotzki P, Pelegrin M, Pelegrin A. Radioimmunotherapy of small solid tumours using monoclonal antibodies labelled with Auger electrons emitters Radioprotection. 43. DOI: 10.1051/RADIOPRO:2008573 |
0.01 |
|
| 2007 |
Larbouret C, Robert B, Linard C, Teulon I, Gourgou S, Bibeau F, Martineau P, Santoro L, Pouget JP, Pelegrin A, Azria D. Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice. International Journal of Radiation Oncology, Biology, Physics. 69: 1231-7. PMID 17967312 DOI: 10.1016/j.ijrobp.2007.07.2372 |
0.01 |
|
| 2006 |
Laurent C, Voisin P, Pouget JP. DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol. International Journal of Radiation Biology. 82: 309-21. PMID 16782648 DOI: 10.1080/09553000600733150 |
0.01 |
|
| 2006 |
Douki T, Ravanat JL, Pouget JP, Testard I, Cadet J. Minor contribution of direct ionization to DNA base damage inducedby heavy ions. International Journal of Radiation Biology. 82: 119-27. PMID 16546910 DOI: 10.1080/09553000600573788 |
0.01 |
|
| 2005 |
Laurent C, Pouget JP, Voisin P. Modulation of DNA damage by pentoxifylline and alpha-tocopherol in skin fibroblasts exposed to Gamma rays. Radiation Research. 164: 63-72. PMID 15966766 |
0.01 |
|
| 2004 |
Pouget JP, Laurent C, Delbos M, Benderitter M, Clairand I, Trompier F, Stéphanazzi J, Carsin H, Lambert F, Voisin P, Gourmelon P. PCC-FISH in skin fibroblasts for local dose assessment: biodosimetric analysis of a victim of the Georgian radiological accident. Radiation Research. 162: 365-76. PMID 15447046 DOI: 10.1667/RR3227 |
0.01 |
|
| 2004 |
Cadet J, Bellon S, Douki T, Frelon S, Gasparutto D, Muller E, Pouget JP, Ravanat JL, Romieu A, Sauvaigo S. Radiation-induced DNA damage: formation, measurement, and biochemical features. Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society For Environmental Toxicology and Cancer. 23: 33-43. PMID 14994993 DOI: 10.1615/JEnvPathToxOncol.v23.i1.30 |
0.01 |
|
| 2003 |
Benderitter M, Vincent-Genod L, Pouget JP, Voisin P. The cell membrane as a biosensor of oxidative stress induced by radiation exposure: a multiparameter investigation. Radiation Research. 159: 471-83. PMID 12643792 DOI: 10.1667/0033-7587(2003)159[0471:TCMAAB]2.0.CO;2 |
0.01 |
|
| 2002 |
Cadet J, Douki T, Frelon S, Sauvaigo S, Pouget JP, Ravanat JL. Assessment of oxidative base damage to isolated and cellular DNA by HPLC-MS/MS measurement. Free Radical Biology & Medicine. 33: 441-9. PMID 12160926 |
0.01 |
|
| 2002 |
Pouget JP, Frelon S, Ravanat JL, Testard I, Odin F, Cadet J. Formation of modified DNA bases in cells exposed either to gamma radiation or to high-LET particles. Radiation Research. 157: 589-95. PMID 11966325 DOI: 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2 |
0.01 |
|
| 2001 |
Pouget JP, Mather SJ. General aspects of the cellular response to low- and high-LET radiation. European Journal of Nuclear Medicine. 28: 541-61. PMID 11357507 DOI: 10.1007/s002590100484 |
0.01 |
|
| 2001 |
Cadet J, Douki T, Pouget JP, Ravanat JL, Sauvaigo S. Effects of UV and visible radiations on cellular DNA. Current Problems in Dermatology. 29: 62-73. PMID 11225202 DOI: 10.1159/000060654 |
0.01 |
|
| 2001 |
Didier C, Pouget JP, Cadet J, Favier A, Béani JC, Richard MJ. Modulation of exogenous and endogenous levels of thioredoxin in human skin fibroblasts prevents DNA damaging effect of ultraviolet A radiation Free Radical Biology and Medicine. 30: 537-546. PMID 11182524 DOI: 10.1016/S0891-5849(00)00502-5 |
0.01 |
|
| 2001 |
Frelon S, Douki T, Ravanat JL, Pouget JP, Tornabene C, Cadet J. High-performance liquid chromatography--tandem mass spectrometry measurement of radiation-induced base damage to isolated and cellular DNA. Chemical Research in Toxicology. 13: 1002-10. PMID 11080049 DOI: 10.1021/TX000085H |
0.01 |
|
| 2000 |
Cadet J, Douki T, Pouget JP, Ravanat JL. Singlet oxygen DNA damage products: formation and measurement. Methods in Enzymology. 319: 143-53. PMID 10907507 DOI: 10.1016/S0076-6879(00)19016-0 |
0.01 |
|
| 2000 |
Pouget JP, Douki T, Richard MJ, Cadet J. DNA damage induced in cells by γ and UVA radiation as measured by HPLC/GC-MS and HPLC-EC and comet assay Chemical Research in Toxicology. 13: 541-549. PMID 10898585 DOI: 10.1021/tx000020e |
0.01 |
|
| 1999 |
Cadet J, D'Ham C, Douki T, Pouget JP, Ravanat JL, Sauvaigo S. Facts and artifacts in the measurement of oxidative base damage to DNA. Free Radical Research. 29: 541-50. PMID 10098458 DOI: 10.1080/10715769800300581 |
0.01 |
|
| 1999 |
Cadet J, Delatour T, Douki T, Gasparutto D, Pouget JP, Ravanat JL, Sauvaigo S. Hydroxyl radicals and DNA base damage. Mutation Research. 424: 9-21. PMID 10064846 DOI: 10.1016/S0027-5107(99)00004-4 |
0.01 |
|
| 1999 |
Pouget JP, Ravanat JL, Douki T, Richard MJ, Cadet J. Measurement of DNA base damage in cells exposed to low doses of γ- radiation: Comparison between the HPLC-EC and comet assays International Journal of Radiation Biology. 75: 51-58. PMID 9972791 DOI: 10.1080/095530099140807 |
0.01 |
|
| 1999 |
Pouget J, Ravanat J, Douki T, Richard M, Cadet J. Use of the comet assay to measure DNA damage in cells exposed to photosensitizers and gamma radiation Journal De Chimie Physique Et De Physico-Chimie Biologique. 96: 143-146. DOI: 10.1051/JCP:1999122 |
0.01 |
|
| 1999 |
Cadet J, Douki T, Gasparutto D, Gromova M, Pouget J, Ravanat J, Romieu A, Sauvaigo S. Radiation-induced damage to DNA: mechanistic aspects and measurement of base lesions Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions With Materials and Atoms. 151: 1-7. DOI: 10.1016/S0168-583X(99)00117-2 |
0.01 |
|
| Hide low-probability matches. |